糖尿病和人工智能超越闭环:对景观,承诺和挑战的回顾
Scott C Mackenzie1, Chris A R Sainsbury2, Deborah J Wake3,4
1Population Health and Genomics, School of Medicine, University of Dundee, Dundee, UK.
Diabetologia
|November 18, 2023
概括
人工智能 (AI) 和数据驱动系统为改善超越1型糖尿病的糖尿病护理提供了巨大的潜力. 本综述探讨了用于患者管理,临床决策和多模式数据集成的AI应用,旨在改变医疗保健效率和结果.
科学领域:
- 糖尿病技术 糖尿病技术
- 医学中的人工智能
- 医疗信息学 医疗信息学
背景情况:
- 目前对糖尿病人工智能的关注主要集中在1型糖尿病技术上,如传感器和.
- 对于所有类型的糖尿病,人工智能和数据分析的更广泛潜力在学术和临床话语中仍未得到充分探索.
- 新兴产品和文献强调了人工智能对提高临床护理和医疗服务效率的承诺.
研究的目的:
- 提供与糖尿病护理相关的AI技术的概述.
- 探索人工智能和数据驱动系统在所有糖尿病类型中的当前和潜在应用.
- 讨论人工智能在糖尿病管理中的整合,益处,危害和障碍.
主要方法:
- 对人工智能技术和在糖尿病中的应用进行文献综述.
- 分析已发表的研究和新兴市场产品.
- 探索人工智能在患者教育,临床决策支持,预测分析和多式联络数据利用方面的作用.
主要成果:
- 人工智能应用包括患者教育,自我管理,诊断支持,治疗建议和并发症预测.
- 多模式数据,包括成像和遗传学,可以被人工智能用于全面的糖尿病护理.
- 潜在的好处包括加强临床护理,提高卫生服务效率和成本效益.
结论:
- 由人工智能驱动的系统有可能在所有类型的糖尿病护理中显著改变.
- 成功的整合需要利益相关者之间的合作,以应对数据交换,健康不平等和监管障碍等挑战.
- 积极的协作对于利用人工智能的好处至关重要,同时减轻糖尿病管理中的风险.
相关概念视频
Issues And Trends In Healthcare Delivery System
5.6K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.6K
Diabetes Mellitus: Overview and Type I Subtype
2.7K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.7K
Diabetes: Management and Pharmacotherapy
289
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
289
Diabetes: Symptoms, Diagnosis, and Complications
554
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
554
Pathophysiology of Diabetes
950
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
950
Hypoglycemia and Glucagon
273
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
273


